NCT00539487已完成不适用
TOP -Study Telmisartan - Therapy of Hypertension and Life-style Changes in Cardiovascular Risk Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5,827
- 试验地点
- 94
- 主要终点
- Blood pressure reduction
研究概览
简要总结
This observational non-interventional study will assess (under conditions of clinical practice in daily routine) the antihypertensive efficacy of telmisartan treatment with or without active promotion of lifestyle changes in hypertensive patients at high cardiovascular risk
详细描述
Study Design:
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients with essential hypertension aged >/= 18 years with one of the following risk factors: history of coronary artery disease or stroke/TIA or peripheral artery disease or diabetes mellitus.
排除标准
- •according to SPC
结局指标
主要结局
Blood pressure reduction
时间窗: 4 month
次要结局
- Change in metabolic parameters Safety
研究者
研究点 (94)
Loading locations...
相似试验
已完成
不适用
Telmisartan Tab HypertensionHypertensionNCT00890084Boehringer Ingelheim2,913
已完成
不适用
Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®HypertensionNCT00927537Bayer2,052
已完成
不适用
Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and PatientsHypertensionNCT02242851Boehringer Ingelheim5,018
已完成
3 期
BIBR 277 Capsule in Patients With Essential HypertensionHypertensionNCT02177448Boehringer Ingelheim225
已完成
不适用
TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or OlderHypertensionNCT02242877Boehringer Ingelheim3,320